Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
24 studies found for:    Open Studies | "Drug Hypersensitivity"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Management of Drug Hypersensitivity in Children
Condition: Drug Hypersensitivity
Intervention:
2 Recruiting Medical Device for Drug Allergy Diagnosis
Condition: Drug Hypersensitivity
Intervention: Procedure: Immediate hypersensitivity to BLC
3 Recruiting Optimal Doses for Drug Provocation Tests to Beta-lactams
Condition: Drug Hypersensitivity
Intervention: Procedure: simplified drug provocation test
4 Recruiting Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization
Condition: Drug Allergy
Intervention: Drug: Omalizumab
5 Recruiting Quality of Life of Patients With a History of Drug Allergy in Thailand
Condition: Quality of Life
Intervention: Other: Questionnaires
6 Recruiting Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment
Conditions: Mild Cognitive Impairment;   Herbal Medicine Allergy
Interventions: Drug: Qinggongshoutao Bolus;   Drug: Ginkgo Biloba Extract 761;   Drug: Placebos
7 Recruiting Comparison Between Corticosteroid and Topical Steroids in the DRESS
Condition: Drug Rash With Eosinophilia and Systemic Symptoms
Interventions: Drug: Prednisone;   Drug: Clobetasol
8 Recruiting Severe Cutaneous Adverse Reactions in Thailand
Conditions: Steven-Johnson Syndrome;   Toxic Epidermal Necrolysis;   Drug Reaction With Eosinophilia and Systemic Symptoms;   Acute Generalized Exanthematous Pustulosis;   Generalized Bullous Fixed Drug Eruption
Intervention:
9 Recruiting Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
Conditions: Allergic Cutaneous Vasculitis;   Urticaria;   Psoriasis;   Acne;   Bullous Skin Diseases;   Sterile Pustulosis;   Leprosy;   Pneumocystis Pneumonia
Interventions: Drug: Dapsone;   Genetic: HLA-B*1301
10 Recruiting MARY DUOL REPAIR BALM IN THE PREVENTION OR REDUCING ANTINEOPLASIC AGENTS' SKIN TOXICITY
Condition: Dermatitis, Adverse Drug Reaction
Interventions: Procedure: BALM ARM;   Procedure: PLACEBO ARM
11 Recruiting The Topical Application of Vitamin B6 in Palmar-Plantar Erythrodysesthesia
Condition: Palmar-Plantar Erythrodysesthesia
Interventions: Device: Vitamin B6 cream;   Device: Placebo Vitamin B6 cream
12 Recruiting Testing the Effectiveness of Henna on Managing PPE
Condition: Palmar-plantar Erythrodysesthesia (PPE)
Interventions: Drug: Henna;   Drug: Placebo
13 Not yet recruiting Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)
Condition: Asthma, Aspirin-Induced
Interventions: Drug: Ifetroban Oral Capsule;   Drug: Placebo Oral Capsule
14 Not yet recruiting Role of Inflammatory Mediators in AERD
Condition: Asthma, Aspirin-Induced
Intervention: Drug: aspirin
15 Not yet recruiting Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer
Condition: Hand Foot Syndrome
Interventions: Drug: Traditional Chinese Medicine Formula LC09;   Other: Placebo
16 Recruiting HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction
Conditions: Stevens-Johnson Syndrome;   Kidney Failure, Chronic
Intervention: Genetic: HLA-B*5801 test
17 Not yet recruiting Cyclosporine and Etanercept in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolyses
Interventions: Drug: cyclosporin A;   Drug: Etanercept 50 MG Solution for Injection;   Drug: Placebos
18 Recruiting Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study
Condition: Toxic Epidermal Necrolysis
Interventions: Drug: Isotretinoin;   Other: Placebo
19 Recruiting G-CSF in the Treatment of Toxic Epidermal Necrolysis
Condition: Stevens - Johnson Syndrome
Interventions: Drug: recombinant granulocyte - colony stimulating factor;   Drug: NaCl 0.9%
20 Not yet recruiting Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Clobetasol 0.05% ointment

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.